ABSTRACT
During an epidemic, accurate long term forecasts are crucial for decision-makers to adopt appropriate policies and to prevent medical resources from being overwhelmed. This came to the forefront during the covid-19 pandemic, during which there were numerous efforts to predict the number of new infections. Various classes of models were employed for forecasting including compartmental models and curve-fitting approaches. Curve fitting models often have accurate short term forecasts. Their parameters, however, can be difficult to associate with actual disease dynamics. Compartmental models take these dynamics into account, allowing for more flexible and interpretable models that facilitate qualitative comparison of scenarios. This paper proposes a method of strengthening the forecasts from compartmental models by using short term predictions from a curve fitting approach as synthetic data. We discuss the method of fitting this hybrid model in a generalized manner without reliance on region specific data, making this approach easy to adapt. The model is compared to a standard approach; differences in performance are analyzed for a diverse set of covid-19 case counts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is made possible by the generous support of the American People through the United States Agency for International Development (USAID). The work described in this article was implemented under the TRACETB Project, managed by WIAI under the terms of Cooperative Agreement Number 72038620CA00006. The contents of this manuscript are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No approval or exemption was required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Work done during an internship with Wadhwani AI.
nayana.bannur{at}wadhwaniai.org
alpan{at}wadhwaniai.org
vshah0350{at}gmail.com
jerome{at}wadhwaniai.org
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos